{"version":"1.0","type":"link","title":"The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma.","author_name":"Hsu YC 외","author_url":"https://prs-insight.online/author/Hsu%20YC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/108657","thumbnail_width":1200,"thumbnail_height":630}